Erik H. Knelson

1.9k total citations
22 papers, 703 citations indexed

About

Erik H. Knelson is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Erik H. Knelson has authored 22 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Erik H. Knelson's work include Neuroblastoma Research and Treatments (5 papers), interferon and immune responses (4 papers) and Lung Cancer Research Studies (4 papers). Erik H. Knelson is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), interferon and immune responses (4 papers) and Lung Cancer Research Studies (4 papers). Erik H. Knelson collaborates with scholars based in United States, Japan and Italy. Erik H. Knelson's co-authors include Gerard C. Blobe, David A. Barbie, Dafna Bar‐Sagi, Lecia V. Sequist, Karthikeyan Mythreye, Jacob Sands, Shetal Patel, Saemi Han, Michael B. Armstrong and Tran C. Thai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Erik H. Knelson

22 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik H. Knelson United States 15 397 214 183 166 109 22 703
Praveena Thiagarajan United States 11 290 0.7× 241 1.1× 143 0.8× 65 0.4× 112 1.0× 17 597
Amir Ben‐Shmuel Israel 13 508 1.3× 337 1.6× 197 1.1× 77 0.5× 146 1.3× 29 890
Sylvie Monferran France 15 526 1.3× 256 1.2× 108 0.6× 134 0.8× 235 2.2× 20 919
Jianghong Man China 13 395 1.0× 182 0.9× 75 0.4× 71 0.4× 159 1.5× 17 662
Jared J. Fradette United States 16 319 0.8× 272 1.3× 171 0.9× 107 0.6× 132 1.2× 22 669
Shi-Juan Mai China 16 690 1.7× 242 1.1× 90 0.5× 127 0.8× 306 2.8× 19 981
Gabriella Proietti Italy 12 276 0.7× 149 0.7× 96 0.5× 55 0.3× 187 1.7× 14 738
Joshua W. Collins United States 7 337 0.8× 127 0.6× 112 0.6× 71 0.4× 71 0.7× 12 571
Zane Kalniņa Latvia 16 570 1.4× 151 0.7× 157 0.9× 48 0.3× 211 1.9× 26 829
Hirotaka Matsumura Japan 8 577 1.5× 146 0.7× 234 1.3× 98 0.6× 144 1.3× 9 880

Countries citing papers authored by Erik H. Knelson

Since Specialization
Citations

This map shows the geographic impact of Erik H. Knelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik H. Knelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik H. Knelson more than expected).

Fields of papers citing papers by Erik H. Knelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik H. Knelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik H. Knelson. The network helps show where Erik H. Knelson may publish in the future.

Co-authorship network of co-authors of Erik H. Knelson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik H. Knelson. A scholar is included among the top collaborators of Erik H. Knelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik H. Knelson. Erik H. Knelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murayama, Takahiko, Navin R. Mahadevan, Catherine B. Meador, et al.. (2024). Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer. Cancer Research Communications. 4(9). 2399–2414. 10 indexed citations
2.
Kitajima, Shunsuke, Fengkai Li, Nagib Ahsan, et al.. (2023). The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells. Communications Biology. 6(1). 65–65. 7 indexed citations
3.
Campisi, Marco, Sarah E. Shelton, Minyue Chen, et al.. (2022). Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer Immunotherapies. Cancers. 14(15). 3561–3561. 16 indexed citations
4.
Hong, Deli, Erik H. Knelson, Yixiang Li, et al.. (2021). Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer. Cancer Research. 82(2). 248–263. 25 indexed citations
5.
Tani, Tetsuo, et al.. (2021). KRAS G12C inhibition and innate immune targeting. Expert Opinion on Therapeutic Targets. 25(3). 167–174. 6 indexed citations
6.
Gupta, Saksham, Hassan Y. Dawood, Alexandra Giantini-Larsen, et al.. (2021). Surgical and Peri-Operative Considerations for Brain Metastases. Frontiers in Oncology. 11. 662943–662943. 20 indexed citations
7.
Knelson, Erik H., Shetal Patel, & Jacob Sands. (2021). PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses. Cancers. 13(4). 727–727. 43 indexed citations
8.
Campisi, Marco, Shriram K. Sundararaman, Sarah E. Shelton, et al.. (2020). Tumor-Derived cGAMP Regulates Activation of the Vasculature. Frontiers in Immunology. 11. 2090–2090. 48 indexed citations
9.
Bar‐Sagi, Dafna, Erik H. Knelson, & Lecia V. Sequist. (2020). A bright future for KRAS inhibitors. Nature Cancer. 1(1). 25–27. 52 indexed citations
10.
Zhu, Zehua, Tran C. Thai, Navin R. Mahadevan, et al.. (2019). Phosphorylation of RAB7 by TBK1/IKKϵ Regulates Innate Immune Signaling in Triple-Negative Breast Cancer. Cancer Research. 80(1). 44–56. 44 indexed citations
11.
Wagle, Nikhil, Corrie Painter, Michael Dunphy, et al.. (2017). The Metastatic Breast Cancer (MBC) project: Accelerating translational research through direct patient engagement.. Journal of Clinical Oncology. 35(15_suppl). 1076–1076. 19 indexed citations
12.
Knelson, Erik H., et al.. (2017). Heparin‐binding epidermal growth factor‐like growth factor promotes neuroblastoma differentiation. The FASEB Journal. 31(5). 1903–1915. 14 indexed citations
13.
Knelson, Erik H., et al.. (2014). Heparan sulfate signaling in cancer. Trends in Biochemical Sciences. 39(6). 277–288. 152 indexed citations
14.
Knelson, Erik H., et al.. (2014). Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth. Journal of Clinical Investigation. 124(7). 3016–3031. 30 indexed citations
15.
Knelson, Erik H., et al.. (2013). Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma. Journal of Clinical Investigation. 123(11). 4786–4798. 38 indexed citations
16.
Mater, David Van, Erik H. Knelson, Kathleen Kaiser‐Rogers, & Michael B. Armstrong. (2013). Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus. American Journal of Medical Genetics Part A. 161(3). 605–610. 11 indexed citations
17.
Knelson, Erik H., Alok K. Tewari, Michael B. Armstrong, et al.. (2013). Abstract 5041: The type III TGF-beta receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.. Cancer Research. 73(8_Supplement). 5041–5041. 1 indexed citations
18.
Oh, Sun Young, Erik H. Knelson, Gerard C. Blobe, & Karthikeyan Mythreye. (2013). The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53–N-WASP interaction in epithelial cells. Biochemical Journal. 454(1). 79–89. 13 indexed citations
19.
Mythreye, Karthikeyan, Erik H. Knelson, Catherine E. Gatza, Michael L. Gatza, & Gerard C. Blobe. (2012). TβRIII/β-arrestin2 regulates integrin α5β1 trafficking, function, and localization in epithelial cells. Oncogene. 32(11). 1416–1427. 25 indexed citations
20.
Ramirez, Julio J., et al.. (2010). Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory. Behavioural Brain Research. 216(1). 332–340. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Praveena Thiagarajan Breakdown of academic impact, for papers by Amir Ben‐Shmuel Breakdown of academic impact, for papers by Sylvie Monferran Breakdown of academic impact, for papers by Jianghong Man Breakdown of academic impact, for papers by Jared J. Fradette Breakdown of academic impact, for papers by Shi-Juan Mai Breakdown of academic impact, for papers by Gabriella Proietti Breakdown of academic impact, for papers by Joshua W. Collins Breakdown of academic impact, for papers by Zane Kalniņa Breakdown of academic impact, for papers by Hirotaka Matsumura
Rankless by CCL
2026